The Cool Down on MSN3h
Scientists are making headway in gene editing to unlock critical potential within trees: 'These findings ... lay the groundwork for further innovations'Scientists and engineers at North Carolina State University have discovered trees can be used to produce greener, ...
Can we really achieve immortality? Explore the latest scientific breakthroughs, ethical dilemmas, and what the future might ...
Genes contain the essential building instructions for life, guiding cells on which amino acids to assemble in what sequence to produce specific proteins. The human genome codes for ... a cellular ...
An international research team has uncovered a new mechanism crucial to the production of cellular proteins. When this ...
Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...
We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...
New criteria Now, it appears that South Africa has amended its Ethics in Health Research Guidelines to explicitly envisage research that would result in the birth of gene-edited babies. Section 4.3.2 ...
Nobel laureate David Baltimore, chair of the organizing committee for the Second International Summit on Human Genome Editing, talks about the importance of public global dialogue on gene editing.
A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe ...
The newly added language appears to position the country as the first to explicitly permit the use of genome editing ... gene-edited babies. Section 4.3.2 of the guidelines on “Heritable Human ...
Intellia Therapeutics (NASDAQ:NTLA) fell ~9% in the pre-market on Thursday after the biotech announced data from an ongoing Phase 2 trial for NTLA-2002, a CRISPR-based gene editing therapy for an ...
Precision Biosciences has received clearance from regulators in the Eastern European country of Moldova to begin a human trial of a gene editor for chronic … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback